Alnylam Pharmaceuticals, Inc.
RNA therapeutics company appoints Vicki L. Sato as director
Published in Lab Law Weekly, January 6th, 2006
Sato was formerly president of Vertex Pharmaceuticals from 2000 to 2005. Prior to her position as president, she served as the company's chief scientific officer and Chair of the scientific advisory board. Sato is credited with establishing Vertex as a leading innovator in small molecule drug discovery and development, and under her leadership, the company built a robust pipeline of product candidates in the areas of viral disease, autoimmune diseases, and cancer, as well as a portfolio of collaborative partnerships.
Prior to joining Vertex,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2006-01-06)
More Articles from Lab Law Weekly
- Eisai Co., Ltd.
Legal action begins over Aricept ANDA filing - Institute National d'Etudes Demographiques, Paris
AIDS triples the mortality of adults aged 25-44 years in Pointe-Noire - MedImmune, Inc.
FluMist maker acquires rights to reverse genetics patent - MedImmune, Inc.
Pharma company announces senior management hires and promotions - Quick-Med Technologies, Inc.
U.S. Patent and Trademark Office grants patent for Nimbus intellectual property portfolio - Royal Free Hospital, London
Hepatic intraarterial Y-90-DOTA-lanreotide deemed safe palliative treatment of liver metastases - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
